One in two people in the United States, just over half of the population, is affected by a neurological disease or disorder, according to a new systematic analysis by the American Academy of Neurology ...

Beacon of Life Chiropractic highlights the professional background of Dr. Megan McClimon, one of its co-founders, who brings experience from leading chiropractic offices in the Southeast United States ...

The MarketWatch News Department was not involved in the creation of this content. -- NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in ...

Apitegromab improved motor function in SMA patients in a Phase 3 trial analysis, with stronger benefits seen in those treated earlier.

FAYETTEVILLE, GA, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- Spinal cord injury often triggers a cascade of ...

NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravisAarhus, ...

Imagine you are walking through your house or sitting down to watch a movie, and suddenly, a sharp, burning pain shoots ...

Spain has begun using a new genetic ALS therapy that targets the SOD1 mutation and may slow nerve damage in patients with this rare condition.

In 1921, Otto Loewi woke from a dream with the idea for an experiment that proved nerves communicate using chemicals, not just electricity. By showing that stimulating one frog’s heart released a ...

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.

Many infants with the most severe form of spina bifida, called myelomeningocele, experience breathing disruptions during sleep — increasing the risk of cognitive deficits later in life, a new study ...